No: MHRA registration is not the same as approval. In Great Britain, registration is a required regulatory step before an in vitro diagnostic (IVD) is placed on the market; it does not certify, approve, or endorse the device. The manufacturer must also follow the conformity-assessment and marking route that applies to the device and destination market. Northern Ireland has a distinct, EU-aligned framework, so a claim that an IVD is “MHRA registered” does not by itself establish that it can be sold throughout the UK.
What MHRA registration does—and does not—mean
For Great Britain (England, Wales, and Scotland), medical devices including IVDs must be registered with the Medicines and Healthcare products Regulatory Agency (MHRA) before they are placed on the market. The relevant manufacturer or responsible person is responsible for meeting the registration requirement. For non-UK manufacturers seeking Great Britain market access, MHRA guidance says to appoint a single UK Responsible Person for the manufacturer’s devices; that person performs specified tasks, including registration.
As an Amazon Associate I earn from qualifying purchases.
Registration is an administrative and regulatory notification step. It informs the regulator about devices and relevant economic operators; it does not show, by itself, that a device has passed the conformity assessment required for its market route. The MHRA states that registration “does not represent any form of accreditation, certification, approval or endorsement.” MHRA: Register medical devices to place on the market
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Accordingly, “MHRA registered” and “MHRA approved” are not interchangeable claims. The official material describes applicable conformity routes and marking requirements, not a general MHRA approval stamp for all IVDs.
#1 Best Overall
- FDA-Approved & Clinically Trusted: The only oral fluid HIV self-test capable to detect both HIV-1 and HIV-2 antibodies. The same trusted test used by healthcare providers. Approved for use in individuals 14 years of age and older
- Quick & Easy Results in 20 Minutes: Just three simple steps and 20 minutes to know your HIV status, no lab visit or waiting required. Contact the OraSure support call center for confidential expert assistance and guidance if needed. FSA/HSA Eligible
- Pain-Free Oral Swab Testing: Uses a gentle gum swab; no needles, no discomfort, and no mess. Each kit includes: 1 OraQuick test device and vial, 1 Test Stand, 1 "HIV, Testing & Me" educational booklet, 1 instructional guide
- Confidential & Convenient At-Home Testing: Perform your test anytime, anywhere, with complete privacy. No appointments, waiting rooms, or follow-up visits. Ideal for individuals seeking discreet, self-directed HIV testing
- Sustainable & Reliable: Rebranded from OraQuick In-Home HIV Test with eco-friendly packaging; same trusted accuracy and performance as before.
Registration and conformity assessment answer different questions
| Question | Registration | Conformity assessment and marking |
|---|---|---|
| What does it address? | Whether the required device and operator information has been registered with the regulator. | Whether the manufacturer has demonstrated compliance with the legal requirements and route applicable to the device and market. |
| Does it establish device compliance? | No. Registration is not certification, approval, accreditation, or endorsement. | It is the process used to demonstrate conformity; the applicable route may involve a third party. |
| What should a buyer verify? | That the relevant registration requirement has been met for the destination market. | The device category, route, required marking, and any certificate or approved-body involvement. |
In Great Britain, the UK Medical Devices Regulations 2002 (UK MDR 2002) provide the framework, with IVDs addressed in Part IV. A manufacturer must demonstrate conformity through the applicable route. Some IVD categories—including specified listed categories and self-test devices—require assessment by a UK approved body, but that does not mean every IVD requires one. The device’s intended purpose and category determine which route applies. MHRA: Medical devices: conformity assessment and the UKCA mark MHRA: In vitro diagnostic medical devices: guidance on legislation
Great Britain and Northern Ireland have different rules
“UK market” is not precise enough for a regulatory check. Great Britain means England, Wales, and Scotland. Northern Ireland follows EU MDR/IVDR-aligned rules and has different registration and marking arrangements.
Rank #2
- Quick Results: Learn your blood type in just a couple of minutes with this easy-to-use testing kit
- Simple Interpretation: Easily understand your blood type group with clear and straightforward results
- Permanent Record: Keep as a permanent record of your blood type on the durable card for your records or safekeeping
- Reliable Accuracy: Offers a reliable and accurate way to learn your blood type using proven testing technology
- Convenient Home Use: Can be used conveniently at home without the need for laboratory visits
| Destination | Regulatory framework and registration | Marking points |
|---|---|---|
| Great Britain | UK MDR 2002 applies. Medical devices, including IVDs, must be registered with the MHRA before placement on the market. | UKCA is available for compliant devices. Certain CE-marked devices may also be accepted under time-limited, conditional transition arrangements. |
| Northern Ireland | EU MDR/IVDR rules apply. Registration requirements vary according to factors including manufacturer location, authorised-representative location, and device class. | UKCA is not recognised. CE marking is required; CE UKNI is relevant when a UK notified body carries out mandatory third-party conformity assessment. |
For Northern Ireland, MHRA guidance identifies EUDAMED modules that become mandatory from 28 May 2026. Because NI implementation and registration details are date-sensitive, check the current guidance for the specific device and operator circumstances. MHRA: Regulation of medical devices in Northern Ireland
For a device intended for both Great Britain and Northern Ireland, assess each destination separately. A marking or registration status that addresses one market should not be assumed to satisfy the other market’s requirements. MHRA: Regulating medical devices in the UK
Rank #3
- BD Veritor System offers test assays that can be used to process samples provided to the lab in an appropriate transport medium
- The first CLIA-waived Digital Immunoassay (DIA), a new category of diagnostic tests where the assay and instrument work together to combine advances in detection particles, optical image recognition and interpretation algorithms to improve accuracy
- Advanced Particle Technology enhances sensitivity by using a proprietary process to produce highly stable modified colloidal metal particles, helping improve test performance
CE-marked IVD transition arrangements in Great Britain
MHRA guidance describes conditional, time-limited acceptance in Great Britain for certain CE-marked devices. It says EU IVDR-compliant IVDs may be placed on the Great Britain market until 30 June 2030 under the described arrangements. EU IVDD-compliant IVDs may be placed there until the earlier of the relevant certificate’s expiry or 30 June 2030. These dates do not establish eligibility for every CE-marked device: confirm the applicable category, certificate status, and conditions before relying on a transition route. MHRA: Regulating medical devices in the UK MHRA: In vitro diagnostic medical devices: guidance on legislation
What to ask a supplier before relying on a registration claim
Use these questions to establish what the claim covers. They help frame due diligence but do not replace a device-specific regulatory determination.
Rank #4
- FAST & EASY RESULTS IN 1 MINUTE – Simple at-home testing with clear results in as little as 60 seconds. No lab visits, no appointments, no waiting.
- PRIVATE & CONFIDENTIAL AT-HOME TESTING – Test in the comfort of your home with privacy and control from start to finish.
- OVER 99% ACCURATE - Clinically proven to deliver highly accurate results, giving you confidence in your test outcome.
- MORE ACCURATE THAN ORAL TESTS - Designed to provide greater confidence and clarity compared to oral fluid HIV tests.
- SATISFACTION GUARANTEED - If you experience any issues with your test, contact INSTI directly and we will resolve it quickly.
- Which market is intended? Ask whether the product is being supplied for Great Britain, Northern Ireland, or both.
- What is the intended purpose and IVD category? These details affect the applicable conformity route.
- What conformity route applies? Ask whether third-party assessment is required and, if so, which approved body or notified body performed it.
- Which marking supports placement on that market? Check whether the supplier relies on UKCA, CE, or CE UKNI, as applicable, and ask for relevant conformity documentation.
- Who is responsible for a non-UK manufacturer in Great Britain? Ask for the identity of its UK Responsible Person and how the required registration was handled.
- Is a CE transition route being claimed? Ask which EU legislation and certificate status support the claim, and what end date and conditions apply.
How to interpret the answer
A registration entry is evidence of registration, not proof of approval. To assess whether an IVD can be supplied in a particular UK market, match the device’s intended purpose and category to the applicable conformity route, verify the required marking and any third-party assessment, and check the registration obligations for that geography. The relevant legal route depends on device-specific details; the general label “MHRA registered” cannot settle those questions on its own.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minuteQuick Recap
Best Value
- Tests for 5 STDs: An easy-to-use 5-Panel STD test with simple, fast, and private results. Simple HealthKit's 5-Panel STD Test screens for 5 STDs / STIs: Chlamydia, Gonorrhea, Trichomoniasis, HCV & Syphilis.
- Fast, Simple, Private: Getting tested has never been easier. Collect a urine & blood sample from the privacy of your home and send it to our lab for testing. Once the sample is received by our lab, your online results are typically available within 3 - 5 days.
- Free Follow-Up Care: Lab processing is included with your test purchase. If you receive a positive or abnormal test result, follow-up care is included. No extra charge. No hidden fees. It's that simple.
- Physician Approved, HSA / FSA Eligible, Test Intended for 18+ Only: Not Available in NY. Lab is CLIA Certified and CAP Accredited. Results delivered through a HIPAA-compliant portal.
- Fast, Simple, Private: Getting tested has never been easier. Collect a urine & blood sample from home and send it to our lab for testing. Once the sample is received by our lab, your online results are typically available within 3 - 5 days.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
